{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Craig EJ"],"funding":["NCATS NIH HHS","NIDA NIH HHS","NIDDK NIH HHS","NCI NIH HHS"],"pagination":["102005"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8854443"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["78"],"pubmed_abstract":["<h4>Background</h4>Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.<h4>Methods</h4>Using EHR data from the pre-implementation (P: 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primary outcomes: 1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation r"],"journal":["Cancer epidemiology"],"pubmed_title":["Point of care tobacco treatment sustains during COVID-19, a global pandemic."],"pmcid":["PMC8854443"],"funding_grant_id":["P01 CA180945","P30 CA091842","R34 DA052928","K12 DA041449","UL1 TR002345","P50 CA244431","P30 DK092950","R35 CA197573","R01 DA038076"],"pubmed_authors":["Pham G","Ramsey AT","Chen LS","Chen J","Craig EJ","Luke DA","Bierut LJ","Goldberg P","Baker TB","Malone S","Govindan R","James AS","Smock N"],"additional_accession":[]},"is_claimable":false,"name":"Point of care tobacco treatment sustains during COVID-19, a global pandemic.","description":"<h4>Background</h4>Tobacco cessation treatment for cancer patients is essential to providing comprehensive oncologic care. We have implemented a point of care tobacco treatment care model enabled by electronic health record (EHR) modifications in a comprehensive cancer center. Data are needed on the sustainability of both reach of treatment and effectiveness over time, including the COVID-19 pandemic.<h4>Methods</h4>Using EHR data from the pre-implementation (P: 5 months) and post-implementation periods (6 month-blocks, T1-T5 for a total of 30 months), we compared two primary outcomes: 1) reach of treatment among those smoking and 2) effectiveness assessed by smoking cessation among those smoking in the subsequent 6 month period. We analyzed the data using generalized estimation equation r","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Jun","modification":"2025-04-18T12:18:04.391Z","creation":"2025-04-06T21:51:40.421Z"},"accession":"S-EPMC8854443","cross_references":{"pubmed":["34446379"],"doi":["10.1016/j.canep.2021.102005"]}}